Scientific notes

Organ-on-a-Chip: A New Paradigm for Drug Development

Introduction

Organ-on-a-Chip is a potential, multidisciplinary method for in-vitro modeling of disease, drug screening, and precision medicine that simulates in-vitro physiology and pathology.
Organ-on-a-chip technology may be integrated organically into the drug development pipeline for preclinical screening, testing, and translating novel medicines from early drug discovery to bridging the gap between animal and human subject research.

In the future, it will be unprecedented to promote its biomedical applications through further development of customized organ-on-a-chip and ongoing integration of novel engineering tools (i.e. automation handling, 3D printing, in situ multi-Sensor systems) and biological concepts (e.g. patient-induced pluripotent stem cells and organoids).

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “The pharmaceutical industry has been desperately searching for efficient drug discovery methods. Organ-on-a-Chip, a cutting-edge technology that can emulate the physiological environment and functionality of human organs on a chip for disease modeling and drug testing, shows great potential for revolutionizing the drug development pipeline.

However, successful translation of this novel engineering platform into routine pharmacological and medical scenarios remains to be realized. In this review, we discuss how the Organ-on-a-Chip technology can have critical roles in different preclinical stages of drug development and highlight the current challenges in translation and commercialization of this technology for the pharmacological and medical end-users.

Moreover, this review sheds light on the future developmental trends and need for a next-generation Organ-on-a-Chip platform to bridge the gap between animal studies and clinical trials for the pharmaceutical industry.”.

References

Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development. Trends Pharmacol Sci. 2021 Feb;42(2):119-133. doi: 10.1016/j.tips.2020.11.009. Epub 2020 Dec 16. PMID: 33341248; PMCID: PMC7990030.

Related Posts

Yannick Jadot Mentions Cherry Biotech’s Organ-on-Chip Technolog...
Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing by Yannick Jadot during his interview by Jean...
Read more
3d-cell-culture-hepatocytes-SARS-CoV-2
Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein...
Introduction SARS-CoV-2 is the virus that caused the COVID-19 pandemic and its devastating effects on global health and economics. The virus...
Read more
3d-cell-culture-microfluidics-picture-from-NIST
Gradients generation for cell biology in microfluidics...
Chemical gradients play a key role in many biological processes and regulate a number of cellular functions in vivo. Indeed, there are sever...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy